The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 21, 2023

Filed:

Apr. 30, 2017
Applicant:

Biolegend, Inc., San Diego, CA (US);

Inventors:

Dhanesh Gohel, San Diego, CA (US);

Hong Zhang, La Jolla, CA (US);

John Ransom, Encinitas, CA (US);

Assignee:

BIOLEGEND, INC., San Diego, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
B01J 20/06 (2006.01); C12N 5/0789 (2010.01); G01N 33/543 (2006.01); C12N 15/10 (2006.01); G01N 33/552 (2006.01); B01J 20/10 (2006.01); B01J 20/24 (2006.01); B01J 20/28 (2006.01); C07K 16/28 (2006.01); C12N 5/0783 (2010.01); A61K 35/28 (2015.01); B01J 20/32 (2006.01); B03C 1/015 (2006.01); B03C 1/28 (2006.01);
U.S. Cl.
CPC ...
C12N 5/0647 (2013.01); A61K 35/28 (2013.01); B01J 20/06 (2013.01); B01J 20/10 (2013.01); B01J 20/103 (2013.01); B01J 20/24 (2013.01); B01J 20/28007 (2013.01); B01J 20/28009 (2013.01); B01J 20/28021 (2013.01); B01J 20/3204 (2013.01); B01J 20/328 (2013.01); B01J 20/3217 (2013.01); B01J 20/3236 (2013.01); B01J 20/3289 (2013.01); B01J 20/3293 (2013.01); B03C 1/015 (2013.01); B03C 1/28 (2013.01); C07K 16/2812 (2013.01); C12N 5/0637 (2013.01); C12N 15/1013 (2013.01); G01N 33/54326 (2013.01); G01N 33/54333 (2013.01); G01N 33/54346 (2013.01); G01N 33/552 (2013.01); B03C 2201/18 (2013.01); B03C 2201/26 (2013.01);
Abstract

The methods of the invention employ targeted magnetic particles, preferably targeted nanomagnetic particles, and targeted buoyant particles such as buoyant microparticles and microbubbles. Among the benefits of the invention is the ability to combine targeted magnetic particles with differentially targeted buoyant particles to achieve separation of two or more specifically cell targeted populations during the same work flow.


Find Patent Forward Citations

Loading…